26 May 2013
Keywords: Bayer, Xarelto, Visanne, VTE, Endometriosis, FDA, Europe, USA
Article | 07 December 2009
German drug major Bayer announced over the weekend details of data from the EINSTEIN Extension study for Xarelto (rivaroxaban), under ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.